Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid.
Yang LiuYing PangBoqun ZhuOndrej UherVeronika CaisovaThanh-Truc HuynhDavid TaiebKaterina Hadrava VanovaHans Kumar GhayeeJiri NeuzilMark LevineChunzhang YangKarel PacakPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
The data here demonstrate that targeting redox homeostasis as a cancer vulnerability with pharmacologic ascorbic acid is a promising therapeutic strategy for SDHB-mutated PCPGs.